✦ LIBER ✦

Levonorgestrel-Releasing Intrauterine System Alone as Primary Treatment in Young Women with Early Endometrial Cancer: Case Report

✍ Scribed by Fambrini, Massimiliano; Bargelli, Gianni; Peruzzi, Elena; Buccoliero, Anna Maria; Pieralli, Annalisa; Andersson, Karin L.; Scarselli, Gianfranco; Gallorini, Marcella; Zolfanelli, Federica; Marchionni, Mauro

Book ID: 122632025
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 352 KB
Volume: 16
Category: Article
ISSN: 1553-4650
DOI: 10.1016/j.jmig.2009.05.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined medroxyprogesterone acetate/lev

Combined medroxyprogesterone acetate/levonorgestrel–intrauterine system treatment in young women with early-stage endometrial cancer

✍ Kim, Mi Kyoung; Seong, Seok Ju; Kim, You Shin; Song, Taejong; Kim, Mi-La; Yoon, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Progestin in endometrial cancer therapy:

Progestin in endometrial cancer therapy: Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: Report of seven cases and review of the literature. Cancer 1997;79:320-7.

📂 Article 📅 1997 🏛 American College of Obstetrics and Gynecology 🌐 English ⚖ 541 KB

Cost-effectiveness analysis of anastrozo

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB